Skip to main content
. 2013 Nov 21;4(11):e924. doi: 10.1038/cddis.2013.437

Figure 3.

Figure 3

Aβ42 promotes NSPCs senescence. (a) NSPCs were treated with Aβ42 (0, 2.5, 5 or 10 μM) for 5 days, and then detected by SA-β-gal staining. The senescent NSPCs were observed by blue cells staining visualized under an inverted microscope. Pictures were acquired and analyzed using the NIS Nikon software. (b) The percentage of SA-β-gal-positive cells was quantified by counting 102 cells on six separate fields for each condition. (c) Immunoblot for levels of p16 and pRb expressions in NSPCs treated with different concentrations of Aβ42. (d) Quantification by densitometric scanning was presented, and results were normalized to the untreated condition. The mean±S.D. of three independent experiments is shown. *P<0.05, **P<0.01 compared with untreated NSPCs. Scale bar=100 μm

HHS Vulnerability Disclosure